Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8958611 | Arthroplasty Today | 2018 | 5 Pages |
Abstract
Routine prophylactic TXA administration for elective primary hip and knee replacement reduces the likelihood of postoperative transfusion with a number needed to treat of 9. Cost savings may be as high as £155.90 per case, and no safety concerns were noted.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Llion Davies, Kylie Bainton, Robyn Milne, Peter Lewis,